10Y annualized return is
very good
at 14.9% per year
SYK has met or exceeded earnings expectations in
all
recent quarters (10/10)
Moderate Price-to-Sales Ratio
Strong Gross Profit Margin
High Price-to-Earnings Ratio
Relatively Low Return on Equity
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Stryker exhibits strong business quality with solid financial performance, strategic acquisitions, and operational efficiency. Future prospects remain positive with sustained growth expectations and a robust innovation pipeline, though challenges exist in the spinal implants segment and potential short-term dilution from acquisitions.
Analysis Date: January 28, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Stryker Corporation is a company that makes medical equipment and devices to help doctors treat patients. They create products used in surgeries, like joint replacements for hips and knees, as well as tools for brain and spine operations. Stryker also provides emergency medical equipment and devices that help patients in hospitals. They sell their products to doctors and hospitals around the world, helping improve healthcare and patient care.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect SYK's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact SYK's performance.
Access Full Risk AnalysisTrailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights